Cfs
+76%
est. 2Y upside i
Rank
#675
Sector
Fusion Energy
Est. Liquidity
~5Y
Data Quality
Data: MediumCFS offers a highly speculative but potentially explosive equity opportunity.
Last updated: July 19, 2026
CFS achieves technical milestones like first plasma or Q>1, boosting investor confidence. Common stock value doubles from $1.15B to $2.3B (total valuation $9.15B), net of 20% dilution.
Steady progress toward commercialization, valuation reaches $12B. Common stock value rises to $5.15B (274% gross), net of 20% dilution yields 154% upside.
Significant delays or funding shortfall cause valuation to fall below $6.85B. Preference stack wipes out common equity, resulting in -100% return.
Preference Stack Risk
severeFunding Intensity
8560%Total funding of $6.85B is 85.6% of the $8B valuation, so common equity is only $1.15B. Any exit below $6.85B yields zero for common.
Dilution Risk
highCFS will likely need more capital before generating revenue, potentially diluting common by 15-25% within 2 years.
Secondary Liquidity
limitedSecondary market trades exist at ~$241.78/share but volume is thin; employee liquidity may be restricted until an IPO.
Questions to Ask at the Interview
Strategic questions based on Cfs's data — designed to show you've done your homework.
- 1
“What concrete milestones will CFS achieve in the next 2 years to justify a valuation increase?”
- 2
“How does CFS plan to generate revenue before commercial fusion plants are built?”
- 3
“Given the $6.85B raised, what is the expected dilution for new equity grants, and is secondary liquidity available for employees?”
Community
Valuation Sentiment
Our model estimates +76% upside. What do you think?
Anonymous. Do not share material non-public information.
Community Discussion
Comments are reviewed before they appear publicly.
Loading comments...
Disclaimer: This analysis is AI-generated and does not constitute financial or career advice. Always conduct your own due diligence.